Loading provider…
Loading provider…
Pulmonary Disease Physician in Philadelphia, PA
NPI: 1013905157Primary Practice Location
TEMPLE UNIVERSITY HOSPITAL
100 E Lehigh Ave, Philadelphia, PA
Primary Employer
Temple Faculty Pulmonary Associates
templehealth.org
HQ Phone
Get MD Gerard's Phone Numberphone_androidMobile
Get MD Gerard's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardPA State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 476 | 757 |
| 2 | 99215Established patient office or other outpatient, visit typically 40 minutes | 219 | 429 |
| 3 | 99204New patient office or other outpatient visit, 45-59 minutes | 140 | 140 |
| 4 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 54 | 144 |
| 5 | 99291Critical care delivery critically ill or injured patient, first 30-74 minutes | 53 | 111 |
Air pollution and COPD: GOLD 2023 committee report.
Authors: Antonio Anzueto, Meilan Han, Bartolome Celli
Journal: Eur Respir J
Publication Date: 2023-05-11
Authors: Robert Merritt, Peter Mazzone, Sudish Murthy, Billy Loo, Robert Suh, Raymond Mak, Michael Lanuti, Garrett Walsh, James Luketich, Arjun Pennathur, Michael Liptay, Gaetano Rocco, Brian Pettiford
Journal: Semin Thorac Cardiovasc Surg
Publication Date: 2024-12-12
Lead Sponsor: Regeneron Pharmaceuticals
Collaborators: Sanofi
Intervention / Treatment: DRUG: Placebo, DRUG: Sarilumab
Lead Sponsor: Eli Lilly and Company
Collaborators: AbCellera Biologics Inc., Shanghai Junshi Bioscience Co., Ltd.
Intervention / Treatment: DRUG: Placebo, DRUG: LY3819253, DRUG: LY3832479, DRUG: LY3853113
Lead Sponsor: Eli Lilly and Company
Collaborators: AbCellera Biologics Inc.
Intervention / Treatment: DRUG: Placebo, DRUG: LY3819253